Breast and Other Cancer Dormancy as a Therapeutic Endpoint: Speculative Recombinant T Cell Receptor Ligand (RTL) Adjuvant Therapy Worth Considering?

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-10-251
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Bisphosphonates as Adjuvant Therapy for Breast Cancer

Women's Health
Medicine
2006English

The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2003English

Oral Bisphosphonates as Adjuvant Therapy for Operable Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2006English

Mutated Pathways as a Guide to Adjuvant Therapy Treatments for Breast Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2015English

Breast-Cancer Adjuvant Therapy With Zoledronic Acid

New England Journal of Medicine
Medicine
2012English

Epirubicin and Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy for Early Breast Cancer

New England Journal of Medicine
Medicine
2006English

Adjuvant Endocrine Therapy in Early Postmenopausal Breast Cancer

Breast Care
SurgeryOncology
2008English

Adjuvant Therapy After Preoperative Treatment for Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
2009English

Long Term Adjuvant Therapy for Primary Breast Cancer

BMJ
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy